NTA: Nanoparticle Toxicity
White Paper Feb 26, 2016
At the same time as an increasing interest in, and rapid development of, a wide range of materials and products containing nanoscale structures and engineered nanoparticles, awareness has grown that the longer term potential toxic effects of such materials and their potential environmental impact are poorly understood. Existing methods have been assessed and new methods sought by which such materials could be analyzed on a routine basis during development and manufacture.
The use of Nanoparticle Tracking Analysis as a rapid and information-rich multiparameter nanoparticle characterization technique which allows the user to obtain number frequency particle size distributions of polydisperse nanoparticulate systems has resulted in its rapid adoption as an interesting new technique in a wide range of sectors within environmental and toxicity studies. This Chapter addresses some of the latest work in the literature in which NTA has been proposed, used and assessed in the study of nanoparticle toxicity and environmental impact.
NTA has found use in a variety of investigations researching the toxicity and environmental impact of nanoparticles. As well as being used to determine the size of particles in investigations into the toxicity of carbon nanotubes and nanoparticulate metals, NTA has also been used in investigations on the interactions of nanoparticles with organisms at a cellular level and the development of methods for the testing of toxicity. NTA has proved to be a useful tool in determining both particle size and concentration of nanomaterials in wastewater analysis.
Related White Papers
Fully Automated Sensitive Determination of Immunosuppressant Drugs in Whole Blood, using High Quality Internal StandardizationWhite Paper
Measurement of immunosuppressant drugs is essential during organ transplantation. Under-dosing can lead to organ rejection, while over-dosing can cause serious toxicity.READ MORE
7 Key Factors When Considering a Benchtop X-ray DiffractometerWhite Paper
In this white paper, our marketing director of the America’s Kathy Macchiarola outlines the important decisions factors that are key requirements and help you select a benchtop system ideal for your situation and your needs.READ MORE
Supporting the Pharmaceutical Industry with 21 CFR Part 11 Compliance ReadinessWhite Paper
The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.READ MORE
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018